Expected Recognition of an Extraordinary Gain from the Sale of Investment Securities
The Company's consolidated subsidiary (company name Not disclosed)
One listed security held by the Company's consolidated subsidiary (security name Not disclosed)
To improve capital efficiency and strengthen the financial position through the sale of investment shares held for pure investment purposes
Approximately ¥140 million (gain on sale of investment securities, scheduled to be recognized as an extraordinary gain)
The consolidated accounting period for the second quarter of the fiscal year ending December 2026
The consolidated earnings forecasts for the second quarter (cumulative) and full fiscal year ending December 2026 are currently under review, including the impact of other factors. If revisions are necessary, the Company will provide timely disclosure.
The sale is scheduled for May 2026, and the gain on the sale is scheduled to be recognized as an extraordinary gain in the consolidated accounting period for the second quarter of the fiscal year ending December 2026. The earnings forecasts will be reviewed, including the impact of other factors, and any necessary revisions will be disclosed promptly.
If revisions to the earnings forecasts are necessary, the Company will provide timely disclosure.
| Item | Details |
|---|---|
| Event name | Expected Recognition of an Extraordinary Gain from the Sale of Investment Securities |
| Date of occurrence | May 2026 (planned sale period; specific date of occurrence Not disclosed) |
| Subject Entity | The Company's consolidated subsidiary (company name Not disclosed) |
| Target Locations / Products | One listed security held by the Company's consolidated subsidiary (security name Not disclosed) |
| Cause | To improve capital efficiency and strengthen the financial position through the sale of investment shares held for pure investment purposes |
| Amount of Impact on Business Performance | Approximately ¥140 million (gain on sale of investment securities, scheduled to be recognized as an extraordinary gain) |
| Accounting period in which recognized | The consolidated accounting period for the second quarter of the fiscal year ending December 2026 |
| Impact on Earnings Forecast | The consolidated earnings forecasts for the second quarter (cumulative) and full fiscal year ending December 2026 are currently under review, including the impact of other factors. If revisions are necessary, the Company will provide timely disclosure. |
| Outlook | The sale is scheduled for May 2026, and the gain on the sale is scheduled to be recognized as an extraordinary gain in the consolidated accounting period for the second quarter of the fiscal year ending December 2026. The earnings forecasts will be reviewed, including the impact of other factors, and any necessary revisions will be disclosed promptly. |
| Planned follow-up disclosure | If revisions to the earnings forecasts are necessary, the Company will provide timely disclosure. |
Items this document does not state (15)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To improve capital efficiency and strengthen the financial position by selling investment shares held for pure investment purposes.